JAK inhibitor PF-06263276, Purity ≥98%

Cat. No.: X23-10-ZQ408

JAK inhibitor PF-06263276, Purity ≥98%

Synonym: PF-06263276; 1421502-62-6; 86YZ7HCC8V; {2-[6-(2-Ethyl-5-fluoro-4-hydroxyphenyl)-2H-indazol-3-Yl]-3,4,6,7-tetrahydro-5H-imidazo[4,5-C]pyridin-5-Yl}[5-(piperidin-1-Yl)pyrazin-2-Yl]methanone; JAK inhibitor

  • CAS Number: 1421502-62-6
  • Compound CID: 135567296
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PF-06263276 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and Tyk2.
Molecular Weight
566.63
Molecular Formula
C31H31FN8O2
Targets
JAK1: 2.2 nM; JAK2: 23.1 nM; JAK3: 59.9 nM; Tyk2: 29.7 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
PF-06263276 can be employed to investigate inhibition of JAK kinases, particularly JAK2.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.